Neoplasms, Unknown Primary: Clinical Trials

6 trials for Neoplasms, Unknown Primary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6

Follow Neoplasms, Unknown Primary: new trials by email Literature Review of Neoplasms, Unknown Primary trials Research Report on Neoplasms, Unknown Primary

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS
Dexamethasone, Placebo - Analgesia, Surgery
Phase 3CompletedCopenhagen University Hospital, Rigshospitalet182020-08-182023-03-16
Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary
tissue-of-origin (ORIGIN-PanCA○R) profiling - Cancer of Unknown Primary Site
Phase 3CompletedFudan University1822017-09-182022-01-24
Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP
Cancer Type ID test, No test Empiric strategy - Neoplasms, Unknown Primary
Phase 3CompletedGustave Roussy, Cancer Campus, Grand Paris2432012-03-222020-02-17
Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
Etoposide, Gemcitabine, Irinotecan - Neoplasms, Unknown Primary
Phase 3CompletedSCRI Development Innovations, LLC1982003-09-012013-05-03
Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
radiation therapy - Carcinoma of Unknown Primary
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC6002002-07-012018-07-09
Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer
mitomycin C, porfiromycin, brachytherapy - Carcinoma of Unknown Primary, Head and Neck Cancer
Phase 3CompletedYale University1992-11-012013-07-25

Narrower conditions

Head and Neck Neoplasms (2)  ·  Agnosia (1)  ·  Oropharyngeal Neoplasms (1)  ·  Pain, Postoperative (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Neoplasm Metastasis (6)  ·  Neoplasms (6)  ·  Neoplastic Processes (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Neoplasms by Site (2)  ·  Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Otorhinolaryngologic Neoplasms (1)

Interventions

Radiotherapy (2)  ·  Albumin-Bound Paclitaxel (1)  ·  Brachytherapy (1)  ·  Carboplatin (1)  ·  Dexamethasone (1)  ·  Etoposide (1)  ·  Gemcitabine (1)  ·  Irinotecan (1)  ·  Mitomycin (1)  ·  Paclitaxel (1)  ·  Porfiromycin (1)  ·  etoposide phosphate (1)

Sponsors

Copenhagen University Hospital, Rigshospitalet (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  Fudan University (1)  ·  Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  SCRI Development Innovations, LLC (1)  ·  Yale University (1)

Countries

Denmark (3)  ·  United States (3)  ·  Netherlands (2)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Switzerland (1)

Top investigators

Cai Grau, MD (1)  ·  Esat M. Ozsahin, MD, PhD (1)  ·  James J. Fischer, MD, PhD (1)  ·  John D. Hainsworth, MD (1)  ·  Samy El-Sayed, MD, FFR, FRCR, FRCP (1)  ·  Sharon A. Spencer, MD (1)  ·  Vincent G. Gregoire, MD, PhD (1)

Results publications

PMID 20164695, PMID 39068945